Indraprastha Medical Corporation Ltd vs Kms Medisurgi Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 299.95 as of 23 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 215 on March 2021 to 18.5 on March 2026 . This represents a CAGR of -33.56% over 6 yearsThe P/E Ratio of KMS Medisurgi Ltd changed from 92.2 on March 2021 to 170.9 on March 2026 . This represents a CAGR of 10.83% over 6 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 492.74 crore on March 2021 to ₹ 3407 crore on March 2026 . This represents a CAGR of 38.03% over 6 yearsThe Market Cap of KMS Medisurgi Ltd changed from ₹ 11.25 crore on March 2021 to ₹ 41.75 crore on March 2026 . This represents a CAGR of 24.43% over 6 years The revenue of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 414.57 crore as compare to the Mar '26 revenue of ₹ 372.14 crore. This represent the growth of 11.4% The revenue of KMS Medisurgi Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 88.23 crore as compare to the Mar '26 ebitda of ₹ 67.84 crore. This represent the growth of 30.06% The ebitda of KMS Medisurgi Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 55.85 crore over 9 quarters. This represents a CAGR of 10.33% The net profit of KMS Medisurgi Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of KMS Medisurgi Ltd changed from 13.75 % on March 2021 to 6.6 % on March 2026 . This represents a CAGR of -11.51% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About KMS Medisurgi Ltd

KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then has been launching new concepts which helped the Indian Healthcare industry.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or KMS Medisurgi Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr while Market cap of KMS Medisurgi Ltd is 43 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd?

As of October 25, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹299.95. On the other hand, KMS Medisurgi Ltd stock price is INR ₹132.8.

How do dividend payouts of Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and KMS Medisurgi Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.